Connect your AI

Harrow HROW Intangible Amortization

Intangible Amortization at other companies

Tarsus Pharmaceuticals, Inc.TARS

$240K0.0%

GlaukosGKOS

$8.89M+59.4%

Other financials

Income statement

Revenue$44.2M-7.6%

Gross profit$27.0M-16.3%

Operating income-$22.1M-96.6%

Net income-$27.6M-55.2%

EPS (diluted)-$0.74-48.0%

Balance sheet

Cash & equivalents$94.6M+41.8%

Total debt$308.6M-32.9%

Total equity$28.7M-49.1%

Total assets$419.5M+15.2%

Cash flow

Operating cash flow-$9.0M-146%

CapEx$194.0K+14.1%

Free cash flow-$9.2M-147%

Valuation

Market cap$1.59B+38.4%

Enterprise value$1.81B+13.8%

P/S5.9×+0.5×

Profitability

Gross margin74.1%-0.4pp

Operating margin7.3%+5.2pp

Net margin-19.8%+18.0pp

FCF margin5.7%+5.0pp

Returns & leverage

Return on equity-50%+17.5pp

Debt / equity10.7×+2.6×

Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Harrow's intangible amortization?: Harrow (HROW) reported intangible amortization of $5.13M in Q1 2026.
How has Harrow's intangible amortization changed year-over-year?: Harrow's intangible amortization increased by 21.4% year-over-year, from $4.23M to $5.13M.
What is the long-term trend for Harrow's intangible amortization?: Over 4 years (2021 to 2025), Harrow's intangible amortization has grown at a 220.5% compound annual growth rate (CAGR), from $161K to $16.99M.
What does intangible amortization mean?: Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.